Vivus (VVUS), Boston Scientific (BSX), CBOE Holdings (CBOE), KB Home (KBH) and Manhattan Associates (MANH) were downgraded by analysts.
Mizuhom downgraded Boston Scientific (BSX) from a "Buy" rating to a "Neutral" rating. They lowered their price target on the company from $7.00 to $5.40.
Roth Capital downgraded Vivus (VVUS) from a "Buy" rating to a "Neutral" rating.
Macquarie downgraded CBOE Holdings (CBOE) from an "Outperform" rating to a "Neutral" rating.
Stifel Nicolaus downgraded KB Home (KBH) from a "Buy" rating to a "Hold" rating.
Benchmark Company downgraded Manhattan Associates (MANH) from a "Buy" rating to a "Hold" rating.
No comments:
Post a Comment